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Background: Cervical facet block (FB) procedures are often used as a diagnostic precursor to radiofrequency
neurotomies (RFN) in the management of chronic whiplash associated disorders (WAD). Some individuals will
respond to the FB procedures and others will not respond. Such responders and non-responders provided a sample of
convenience to question whether there were differences in their physical and psychological features. This information
may inform future predictive studies and ultimately the clinical selection of patients for FB procedures.
Methods: This cross-sectional study involved 58 individuals with chronic WAD who responded to cervical FB
procedures (WAD_R); 32 who did not respond (WAD_NR) and 30 Healthy Controls (HC)s. Measures included:
quantitative sensory tests (pressure; thermal pain thresholds; brachial plexus provocation test); nociceptive flexion
reflex (NFR); motor function (cervical range of movement (ROM); activity of the superficial neck flexors during the
cranio-cervical flexion test (CCFT). Self-reported measures were gained from the following questionnaires: neuropathic
pain (s-LANSS); psychological distress (General Health Questionnaire-28), post-traumatic stress (PDS) and pain
catastrophization (PCS). Individuals with chronic whiplash attended the laboratory once the effects of the blocks had
abated and symptoms had returned.
Results: Following FB procedures, both WAD groups demonstrated generalized hypersensitivity to all sensory tests,
decreased neck ROM and increased superficial muscle activity with the CCFT compared to controls (p < 0.05). There
were no significant differences between WAD groups (all p > 0.05). Both WAD groups demonstrated psychological
distress (GHQ-28; p < 0.05), moderate post-traumatic stress symptoms and pain catastrophization. The WAD_NR
group also demonstrated increased medication intake and elevated PCS scores compared to the WAD_R group
(p < 0.05).
Conclusions: Chronic WAD responders and non-responders to FB procedures demonstrate a similar presentation of
sensory disturbance, motor dysfunction and psychological distress. Higher levels of pain catastrophization and greater
medication intake were the only factors found to differentiate these groups.
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Whiplash associated disorders (WAD) are defined as the
variety of symptoms arising from an initial whiplash in-
jury usually as a result of a motor vehicle crash (MVC)
[1]. The costs associated with WAD are substantial [1-3]
with the majority of costs incurred by those individuals
who transition to chronicity [4]. Approximately 50% of
those injured report pain and disability at 12 months fol-
lowing the initial event [5].
There is now extensive evidence demonstrating marked
physical and psychological changes in individuals with
chronic WAD. These include sensory disturbances of
widespread hypersensitivity [6-8] and hyperexcitable spinal
cord reflexes [9,10] indicative of augmented central ner-
vous system nociceptive processing (central sensitization).
In addition, motor disturbances such as movement loss
and altered muscle recruitment patterns have been clearly
demonstrated [11-13]. Psychological distress (including
affective disturbances, anxiety, depression and posttrau-
matic stress disorder symptoms) is also common in indi-
viduals with chronic WAD [14-16].
From a patho-anatomical perspective, the cervical facet
joint is a common source of nociception in the neck re-
gion in individuals with chronic WAD [17-19]. Diagnosis
of facet-mediated pain is possible through facet blocks
(FB), be it intra-articular blocks (IAB) or comparative
medial branch blocks (MBB) [20,21]. Effective treatment
of facetogenic nociception has been demonstrated with ra-
diofrequency neurotomy (RFN) [22], and may offer benefit
to individuals who do not respond to conservative treat-
ment following whiplash injury [23]. Recent synthesis of
the literature and systematic reviews provide moderate
levels of evidence that FBs effectively for determine of
suitability for RFN [24-26]. Thus understanding the differ-
ences between those who do and do not respond to FB
procedures is important.
Limited data is available describing individuals who do
and do not respond to these procedures. Wasan et al. [27]
showed that high comorbid pscychopathology was associ-
ated with less pain reduction following a single MBB for
facet joint pain. However, this study did not include a wide
range of measures reflecting the physical and psychological
features consistently demonstrated to be present in chronic
WAD. Some of the sensory, motor and psychological mea-
sures may influence responsiveness to these procedures.
For example, central sensitization has been demonstrated
to be a predictor of poor prognosis in individuals with
musculoskeletal pain undergoing conservative treatment
[28,29] and individuals undergoing surgery [30]; whilst cata-
strophization predicts poor response to painful procedures
[31,32] and increased pain and disability ratings post sur-
gery [33]. The presence of posttraumatic stress symptoms
has also been demonstrated to result in more frequent pain
and poorer prognosis in headache patients [34].This preliminary study examined a sample of individ-
uals who did and did not respond to FB as well as
healthy controls to determine whether there were differ-
ences in their physical and psychological features once
the effects of the blocks had abated and symptoms had
returned. It was hypothesized that those who did not
respond would have greater sensory, sensori-motor and
psychological features than the responders and both
groups would be different to the healthy controls. Such
information is important to inform future predictive




This study was conducted in a tertiary spinal intervention
centre in Calgary, Alberta, Canada. A cross-sectional study
design was used to compare the clinical manifestations of
two WAD groups: 1) WAD participants who responded to
cervical facet joint double blockade and subsequently pro-
ceeded to, and were awaiting RFN (WAD_Responders);
2) WAD participants who failed to respond to cervical
facet joint double blockade (WAD_Non-Responders);
and a 3) healthy control group (HC). Individuals were ad-
mitted into the study at a time post-cervical facet joint in-
jections when symptoms had returned and they reported




Consecutive participants were recruited from individuals
aged 18–65 years with WAD Grade II [1] of a dur-
ation > 6 months post MVC who underwent scheduled
cervical spine facet double block procedures (for predom-
inant neck pain) (Intra-articular block - IAB and MBB).
Those who responded (>50% relief of ‘neck’ pain) to both
of the cervical facet double blockade procedures, and who
were scheduled to progress to RFN entered as the WAD
Responder (WAD_R) group. Individuals who did not re-
spond to the initial cervical IAB procedure formed the
WAD Non Responder (WAD_NR) group. Healthy control
individuals with no previous history of neck pain, whiplash
injury or recent treatment for musculoskeletal pain (within
previous 2 years) were recruited from advertisements
placed around the spinal intervention centre.
Exclusion criteria
Individuals were excluded from the study if they were
classifiable as WAD Grade III or IV [1], or sustained a
concussion or loss of consciousness as a result of the
trauma. They were also excluded if their general health sta-
tus prevented them from undergoing cervical facet double
blockade procedure or RFN (e.g. central or peripheral
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lar disease or coronary artery disease; pregnant, psychiatric
history), or if they were not fluent in spoken or written
English. Healthy controls were also excluded on these gen-
eral health status criteria and all participants were excluded
if they had sought recent treatment (previous two years)
for a musculoskeletal condition or had received previous
treatment for neck pain prior to the MVC.
All the participants were unpaid volunteers. Ethical clear-
ance for this study was granted from the medical research
ethics committee of the University of Queensland and the
conjoint health research ethics board at the University of
Calgary. All participants provided informed consent.
Instrumentation
Motor measures
Range of motion Active cervical range of motion (ROM)
was measured using electromagnetic motion sensors
(Fastrak, Polhemus, USA) [35]. One sensor was placed over
the C7 spinous process and the other was attached to the
top of a light skull cup, which was fitted to the participant’s
head and firmly tightened, such that the second sensor sat
on the vertex of the head. Three trials were performed in
each direction (flexion, extension, left and right rotation)
and the means of the three trials were used in analysis. A
computer program was developed to convert the Euler an-
gles into degrees of freedom of motion for the motion of
the head (vertex) relative to the neck (C7 spinous process).
The Fastrak has previously been used in trials of neck pain
and whiplash participants [36] and has shown to be accur-
ate within +/− 0.2 degrees [37].
Cranio-cervical flexion test Surface EMG (Noraxon
Tele Myo 900) was used to measure the activity of
superficial neck flexor muscles (sternocleidomastoid -
SCM) during the five incremental stages of the cranio-
cervical flexion test (CCFT) as described by Jull [11].
The test was performed in supine and used a pressure
biofeedback device (Stabilizer, Chattanooga, USA) placed
sub-occipitally behind the neck to guide performance. It
was inflated to a baseline of 20 mmHg and participants
perform cranio-cervical flexion to increase the pressure
by five progressive increments of 2 mmHg (22 mmHg-
30 mmHg). Each pressure level was maintained for 10 s
and participants rested for 15 s between each stage.
Myoelectric signals were collected from the SCM mus-
cles using Ag–AgCl electrodes (Noraxon, USA) in a bi-
polar configuration.
Electrodes were positioned along the lower one-third
of the muscle bellies of the SCM [38]. Signals were amp-
lified and filtered by a 500 Hz low pass filter (Noraxon
TeleMyo 900, Scottsdale AZ) and sampled at 2000 Hz
(National Instruments DAQ PCI-6221). EMG data were
analyzed as follows: The maximum root mean squared(RMS) value was identified for each trace using a 1 s
sliding window, incremented in 100 ms steps. RMS
values were normalized for each participant, by dividing
the 1 s maximum RMS from each level of the cranio-
cervical flexion test by the 1 s maximum RMS during a
standardized head lift. The baseline EMG data (RMS
value) obtained at rest (20 mmHg) was subtracted from
the measured EMG at each level of this test. The normal-
ized RMS data for the left and right SCMs were averaged
for analysis [11,36].
Quantitative sensory tests
Pressure pain thresholds Pressure pain thresholds (PPTs)
were measured using a pressure algometer (Somedic AB,
Farsta, Sweden). The probe size was 1 cm2 and the rate of
application was set at 40 kPa/sec. PPTs were measured
over the articular pillars of C5/6 bilaterally (which is the
most common facet joint involved in neck pain, (not in-
volving headaches) following whiplash trauma); over the
median nerve trunks anterior to the elbow bilaterally,
and at a bilateral remote site (upper one third of the
muscle belly of tibialis anterior) as previously described
in investigations of chronic WAD [8]. The participants
were requested to push a button when the sensation
first became painful. Triplicate recordings were taken
at each site and the mean value for each site used in the
analysis.
Thermal pain thresholds Thermal pain thresholds were
measured bilaterally over the cervical spine using the
TSA II Neurosensory Analyzer (Medoc Advanced Medical
Systems; Minneapolis, MN, USA). The thermode was
placed over the skin of the mid cervical region and preset
to 32°C, with the rate of temperature change being 1°C per
second. To identify cold pain thresholds (CPT) and heat
pain thresholds (HPT), participants were asked to push a
switch when the cold or warm sensation first became pain-
ful [39]. Triplicate recordings were taken at each site and
the mean value for each site used in the analysis.
Brachial plexus provocation test The brachial plexus
provocation test (BPPT) was performed as described
previously and in the following sequence: gentle shoulder
girdle depression, glenohumeral abduction and external ro-
tation in the coronal plane, forearm supination, wrist and
finger extension, and elbow extension [40]. The range of
elbow extension was measured at the participants’ pain
threshold using a standard goniometer aligned along the
mid humeral shaft, medial epicondyle, and ulnar styloid
[41]. If the participant did not experience pain, the test was
continued until end of available range.
Nociceptive flexion reflex The nociceptive flexion reflex
(NFR) is a polysynaptic spinal withdrawal reflex that is
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[42]. It was performed via electrical stimulation through bi-
polar surface Ag/AgCl-electrodes (inter electrode distance
approximately 2 cm), which were placed just distal to the
left lateral malleolus of the ankle (innervation area of the
sural nerve). EMG reflex responses to electrical stimulation
were recorded from the middle of the biceps femoris and
the (Ag/AgCl-electrodes). The participant lay prone and a
wedge was placed under the ankle to obtain 30 degrees
knee flexion. The EMG signal was amplified and low-pass
filtered 0-500 Hz by a Multichannel EMG (Noraxon,
Scottsdale AZ). Stimulation and recording was controlled
and analyzed with custom software developed specifically
for this test. A 25 ms, train-of-five, 1 ms, square-wave
impulse (perceived as a single stimulus), was delivered
by a computer-controlled constant current stimulator
(Digitimer DS7A, England).
The current intensity was increased from 2 mA in
steps of 2 mA until a reflex was elicited. The program
delivered the impulses at random time intervals, so that
the participants were not aware of when the stimulus
was going to be applied. In this way, voluntary muscle
contraction due to stimulus anticipation was avoided. A
reflex response was defined using the standardized peak
(NFR interval peak z score) EMG activity from biceps
femoris as recommended [43]. The NFR Interval Peak z
score is the NFR interval peak (EMG activity 90 to
150 ms post-stimulation interval)—baseline mean (60 ms
before stimulation)/baseline SD. Rhudy and France [44],
suggest a NFR interval peak z score of greater that 10.32
be used to define a reflex response. The 90 to 150 ms
interval was chosen as it avoids possible contamination
by low threshold cutaneous flexor reflex, startle reactions,
and voluntary movements [44]. The current intensity re-
quired to elicit a reflex response was defined as the NFR
threshold.
Questionnaires
Baseline measures included a description of symptoms,
symptom dominance (unilateral or bilateral) and sever-
ity, crash parameters, treatments since the crash, com-
pensation status, list of medications and demographic
variables including gender, age, marital status, employ-
ment status, education level and duration of neck pain
as per a standard clinical examination.
A single item visual analogue scale (VAS: 0-10 cm)
was used to measure the participants’ pain intensity in
the cervical spine with (0) described as ‘No Pain’ and (10)
as ‘Worst Pain Imaginable’.
Self-reported pain and disability was measured in whip-
lash participants with the Neck Disability Index (NDI) [45].
The NDI consists of 10 items addressing functional activ-
ities such as personal care, lifting, reading, work, driving,
sleeping, and recreational activities and also pain intensity,concentration, and headache which are rated from no dis-
ability (0) to total disability (5). The overall score (out of
100) is calculated by totalling the responses of each individ-
ual item and multiplying by 2. A higher score indicates
greater pain and disability. It is the questionnaire most uti-
lized in WAD research [46].
The s-LANSS is a validated self-report version of the
Leeds Assessment of Neuropathic Symptoms and Signs
pain scale [47]. It consists of seven items and includes
two self-examination items. A score of 12 or greater in-
dicates pain of a predominantly neuropathic nature. It
has been used in previous WAD research [48].
All participants completed the General Health Ques-
tionnaire 28 (GHQ-28) [49] as a measure of general psy-
chological distress. The General Health Questionnaire-28
(GHQ-28) is a 28-item measure of emotional distress in
medical settings that is divided into 4 subscales: somatic
symptoms (items 1 to 7), anxiety/insomnia (items 8 to 14),
social dysfunction (items 15 to 21), and severe depression
(items 22 to 28). Each item has a 4-point rating scale ran-
ging from (0) to (3). The total scores can be used as a
measure of psychological distress, with a higher score
(>23/24) indicating greater distress. The GHQ-28 has been
used in previous research of WAD [15,50].
The Posttraumatic Diagnostic Scale (PDS) [51] was
included to assess symptom severity according to the
Diagnostic and Statistical Manual of Mental Disorders
(fourth edition, text revision; DSM– IV–TR) diagnostic
criteria for post-traumatic stress disorders (PTSD). For
every item, the frequency of the 17 PTSD symptoms
within 1 week is assessed on a 4-point Likert scale, ran-
ging from 0 (never) to 3 (daily). The items referred to a
1-month period prior to the study period. A total symptom
severity score (ranging from 0 to 51) is derived with larger
scores indicating greater symptom severity. The original
PDS demonstrated high internal consistency and good sta-
bility and appeared to be a valid instrument for the assess-
ment of PTSD in survivors of various traumatic events
inclusive of motor vehicle crashes [52,53].
Pain catastrophizing was evaluated using the Pain Cat-
astrophizing Scale (PCS) [31]. This is a 13-item ques-
tionnaire that describes various thoughts and feelings
that individuals can experience when they are in pain,
and requires participants to reflect on past pain experi-
ences and to indicate the degree to which each of the
items applied to them. Each item has a 5-point rating
scale ranging from (0) not at all to (4) all the time and
scores provide a total for the PCS. A total “cut-off score”
of 30 reflects that an individual has clinically relevant
pain catastrophization [54].
In both WAD groups, the following measures were
completed: VAS, NDI, s-LANSS, GHQ-28, PDS and
PCS. In the HC group, only the GHQ-28 questionnaire
was completed.
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Patient screening and participant group allocation
The referring physician nominated the spinal level and
side of the facet joint block based on the individuals’
clinical presentation which the interventional radiologist
reconfirmed based on clinical findings, including estab-
lished pain maps [55]. Patients underwent a diagnostic
IAB. A 25-gauge spinal needle was advanced under fluoro-
scopic guidance, into the target facet joint with the indi-
vidual in the prone position. A small amount of nonionic
contrast (0.5 cc of Omnipaque 300® Amerslan Health,
Oakville, ON, Canada) was used to confirm needle pos-
ition. Subsequently, an injection of 0.5 cc of local anaes-
thetic (1% Bupivicaine; AstraZeneca, Mississauga, ON,
Canada), and 0.5 cc of corticosteroid (Celestone; Celestone
Soluspan®, Schering, Pointe-Claire, Quebec, Canada) was
made into the target facet joint, until resistance was felt. If
the contrast-medication mixture leaked from the joint,
this was noted in the procedure report, as diagnostic spe-
cificity may be affected.
During the post-injection follow-up period (a minimum
of two hours), participants who reported a decrease in
‘neck’ pain intensity of at least 50%, and concurrently re-
ported a significant improvement in symptoms (of their
‘main’ and familiar pain) for the duration of the anaes-
thetic were determined to have responded to the IAB. If
pain returned within the following days or weeks, they
underwent a second diagnostic cervical facet joint block, a
confirmatory MBB as advocated for the diagnosis of facet
joint pain [20,56,57]. The MBBs were only performed at a
time when the familiar pain returned. If an individual had
prolonged relief of pain (generally > 3 months) following
the IAB, then confirmatory MBBs were not performed. As
these individuals did not receive subsequent MBB, a diag-
nosis of ‘facet pain’ could not be confirmed, and these in-
dividuals were not included in the study. The MBB
involved the placement of a 25-gauge spinal needle, under
fluoroscopic guidance, onto the medial branch of the dor-
sal ramus as it courses over the waist of the articular pillar
at each spinal level. An injection of nonionic contrast
material (0.5 cc of Omnipaque 300® Amerslan Health,
Oakville, ON, Canada) was made to confirm needle pos-
ition. Subsequently, 0.5 cc of 2% Lidocaine (AstraZeneca,
Mississauga, ON, Canada), was injected onto the medial
branch of the dorsal ramus. Both medial branches to the
target facet joint were anaesthetized in order to effectively
anaesthetize the joint [57].
For the purposes of this current study, the patient was
assigned to the WAD_R group if they had a successful
response to the MBB (>50% relief of neck pain) for the
duration of the anaesthetic and agreed to participate in
the study.
If the first IAB block was negative, investigations were
either terminated or initiated at another segmental levelthat might reasonably have been responsible for the pain.
In this manner, blocks were continued until all such pos-
sible levels either proved negative or until a positive
response was encountered. This practice was recently rec-
ommended to assist with diagnostic accuracy and in an at-
tempt to reduce the false negative rate [58]. Thus, these
patients underwent procedures directed at their familiar
pain, such that if their predominant symptom was ‘upper’
neck pain, the upper cervical facet joints (C2-4) were
injected, whilst if their predominant symptom was ‘lower’
neck pain, then the lower cervical facet joints (C4-7) were
injected [55]. If an individual had ‘upper’ and ‘lower’ neck
pain, or mid-level neck pain, then all facet joints were
injected (C2-7) to rule out the presence of facet-mediated
pain. A negative response was defined as no relief of pain
with any procedure. These individuals were subsequently
assigned to the WAD_NR group.
Clinically, this diagnostic pathway is used prior to con-
sideration for RFN [59]. There is some discussion in the
literature regarding the optimum percentage of pain relief
an individual should experience to fulfill the operational
definition of a ‘successful response’ [60,61]. To our know-
ledge, only one study has investigated this response in the
cervical spine, with no significant difference in outcomes
reported in patients with either 50% or 80% pain relief
after their diagnostic block [60]. While 80% relief of pain
is cited as the reference standard for research purposes
[62], many clinicians feel that 50% relief is clinically signifi-
cant [63]. From a practical perspective, individuals with
this response were historically noted in our clinic to suc-
cessfully respond to future RFN.
Study measurements
Measurements occurred approximately one month follow-
ing the ‘failed’ IAB (for the WAD_NR group participants),
or ‘successful’ MBB (for the WAD_R participants). All par-
ticipants attended the research laboratory at a time point
following procedures whereby their ‘familiar’ pain had
returned to the level reported prior to receiving the proce-
dures. On arrival at the research laboratory, all partici-
pants underwent an examination by an experienced
physiotherapist with postgraduate qualifications to re-
confirm their eligibility before inclusion in the study. Par-
ticipants were given a written description of the study
procedures and informed consent was gained before pro-
ceeding to the questionnaires and testing. Familiarization
sessions were performed for each measure. Participants
practiced all movements or instructions until they felt
comfortable to proceed.
After completion of the questionnaires, a standard
protocol was used for the order of tests [64]. The partici-
pants were seated, the Fastrak sensors applied and ROM
was measured. The participants were then positioned su-
pine, EMG electrodes were applied, and the CCFT was
Table 1 The prevalence of cervical joints injected (n = 90)
Group (n) C2/3 (%) C3/4 (%) C4/5 (%) C5/6 (%) C6/7 (%)
WAD_R (58) 41 47 33 48 28
WAD_NR (32) 33 34 38 64 42
Legend: WAD_R =WAD Responders; WAD_NR =WAD Non-Responders.
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side was measured first. PPTs were measured in the fol-
lowing order: tibialis anterior, median nerves and C5/6.
Thermal pain thresholds were then measured over the
cervical spine, HPTs followed by CPTs; followed by the
BPPT. The NFR was the final testing procedure. The same
examiner tested all participants. No feedback or cues were
given to the participants regarding their performance on
any tests.
Data analysis
Data were analyzed with Stata 9.0 statistical software.
Based on our previous research [59], our statistical cal-
culations indicated that this study required 26 partic-
ipants (with 80% power at 5% level of significance)
to adequately detect a minimally clinically important
difference for the following physical measures: change in
Tibialis Anterior PPT, change in CPT, or change in NFR
threshold.
Assumptions of normality, nonmulticollinearity, and
homoscedasticity were tested through examination of
histograms, box plot graphs, correlation matrices, and a
plot of predicted to residual values, respectively. If the
data were not normally distributed, transformation of
the data was applied to interval data. PPT, NFR, CCFT
and BPPT data required log transformation. If normality
was not achieved following transformation (CPT, HPT),
medians and interquartile ranges were generated. The
Wilcoxon matched-pairs signed-rank test was used ini-
tially used to determine within participant side to side
differences and followed by the exploratory analysis for
all the measures and in all groups. Where no side-to-
side differences existed (CPT, BPPT), the data from each
side was compiled and averaged, with the mean com-
piled data used for analysis. Where ‘side-to-side’ differ-
ences existed within groups for various measures, the
mean measure of each ‘side’ was analyzed between groups.
There was a significant side to side difference in the
WAD_R group for HPT (p = 0.007). There was also a sig-
nificant difference in PPT measurements between right
and left cervical spine (p = 0.001) and Tibialis Anterior
(p = 0.04) Pin the HC group (p = 0.001). As a result,
group analyses for these measures were performed for
each individual test site performed.
Chi-squared analysis was utilized to determine if there
was a difference in proportions of individuals in the
WAD groups with respect to compensation status, em-
ployment, education, marital status, number of bodily
symptoms and above threshold scores for GHQ-28,
PCS, PDS and s-LANSS.
Multivariate analysis of variance (MANOVA) was per-
formed to investigate the effect of group (WAD_R,
WAD_NR or HC) on the following log-transformed
measures: PPT and CCFT, and normally distributedROM. One way analysis of variance (ANOVA) tests were
used for log-transformed BPPT and NFR measures.
Where there was a significant group difference, post hoc
tests of simple effects were performed to determine where
these differences occurred. Non-parametric Kruskal-Wallis
rank tests were used to determine any significant group
differences for CPT and HPT measures. Non-parametric
tests were used to analyze group differences in the follow-
ing ordinal-scored questionnaires where homoscedasticity
was present, but normality was not achieved (GHQ-28:
Kruskal-Wallis; PCS, PDS and s-LANSS: Mann–Whitney).
Differences between groups were analysed using a priori
contrasts. Significance level was set at 0.05 with Bonferroni
adjustments used (for normally distributed data); and
the Least Significant Difference (LSD) in ranks was calcu-




Ninety individuals undergoing IAB injections fulfilled
the inclusion criteria and agreed to participate (32 males,
58 females, mean age 45.1 +/− 10.6 (SD) years). Fifty-
eight individuals responded to the cervical facet double
block procedure (IAB and MBB: 18 males, 40 females,
mean age 44.9 +/− 11.1 years) and formed the WAD_R
group. The C5/6 facet joint was the most common symp-
tomatic joint either alone or in combination with another
joint (Table 1). Thirty-two individuals did not respond to
the IAB (14 males, 18 females, mean age 45.4 +/− 9.7 years)
and formed the WAD_NR group. Thirty healthy individ-
uals (9 males, 21 females, mean age 44.2 +/− 9.7 years)
formed the HC group. Figure 1 demonstrates the flow of
participants through the study.
The median [range] duration of symptoms post whip-
lash was 42 [9 – 195] months. All participants received
initial treatment following the MVC, consisting mainly
of pharmaceutics (a combination of various medications
such as over-the-counter analgesics, anti-inflammatories,
anti-depressants, opioids and anti-convulsants – Table 2)
and various therapeutic treatments, including physio-
therapy, massage therapy, acupuncture, and chiropractic.
A greater proportion of WAD_NR individuals were tak-
ing each class of medication. Thirty-four participants in
the WAD_R group (59%) and 16 in the WAD_NR group
(50%) were receiving conservative treatment at the time
of participation in the study.
Intra-Articular Facet Joint Injection (IAB)
(n=177)
Success (  50% relief of pain)
(n=69)
Fail (< 50% relief of pain) 
(n= 55)
Success (  50% relief of pain)
(n=58)
Assessed for Study (Analyzed)
Non Responder (WAD-NR)
(n=32)





Diagnostic Medial Branch Block (MBB)
(n=69)
Excluded (n=53)
Not meeting inclusion criteria 
(n=49)
Other reasons (n=4)
Declined to participate (n=23) Declined to participate (n=11)
Figure 1 Flow of participants through the study.
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characteristics for the groups. There were no significant
differences in gender or age between the three groups
(p > 0.2) and no differences in pain (VAS and s-LANSS)
and disability (NDI) scores between the WAD groups
(p > 0.1). Twenty-nine participants in the WAD_R group
(50%) and 19 participants in the WAD_NR group (59%)
were involved in ongoing compensation claims but this
difference was not significant (χ2 = 0.73, 1 d.f., p = 0.39).
Likewise there were no differences between the WAD
groups with respect to the presence of other bodily pain
(number of symptoms), education levels, marriage orTable 2 Medication use at intake of each whiplash
participant
Medication WAD_R (%) WAD_NR (%)
Anti-Inflammatory 38 47
Over-the-counter Analgesics 29 34
Anti-Convulsant 17 19
Opioid 16 25
Muscle Relaxant 9 16
Anti-Depressant (SNRI) 7 9
Anti-Depressant (TCA) 7 16
Legend: WAD_R = WAD Responders; WAD_NR = WAD Non Responders;
n = number; SNRI = Serotonin-Norepinephrine Reuptake Inhibitors; TCA = Tricyclic
Antidepressants.employment status (p > 0.1). WAD groups did not differ
to the healthy control group in relation to education
levels, marriage and employment status (p > 0.1).
Physical measures
Pressure pain thresholds
MANOVA revealed a significant difference between the
three groups at all test sites (neck, median nerve and tibialis
anterior: F12,224 = 4.71, p < 0.001; Table 4). Post-hoc tests
showed that both whiplash groups demonstrated lower
PPTs at all sites compared with the healthy control group
(F6,112 = 9.53, p < 0.001). There were no significant differ-
ences between the whiplash groups (F6,112 = 0.71, p = 0.64).
Thermal pain thresholds
Kruskal-Wallis Rank tests revealed a significant differ-
ence between the mean ranks of thermal thresholds per
individual (for both cold pain threshold (CPT) and heat
pain threshold (HPT) measurements) among the three
groups (H > 18.9, 2 d.f., p < 0.001; Table 4). Post hoc test-
ing revealed that both whiplash groups demonstrated
elevated CPT (LSD > 30.2, p < 0.05) and reduced HPT
(LSD > 30.7, p < 0.05) when compared to the healthy
control group. There were no differences between the two
whiplash groups for either cold pain thresholds (LSD = 5.2,
p > 0.05) or heat pain thresholds on either side of the neck
(LSD < 2.3, p > 0.05).













WAD_R (58) 69% 44.3 (10.4) 44 [9 – 195] 59 (18) 42 (15) 11 [8-17]
WAD_NR (32) 56% 45.4 (9.7) 34 [10 – 190] 63 (19) 47 (14) 13 [8-16]
HC (30) 70% 44.2 (9.7)
Legend: n = number; F = female; M =male; SD = Standard Deviation; VAS = Visual Analogue Scale; NDI = Neck Disability Index; s-LANSS = self administered Leeds
Assessment of Neuropathic Symptoms and Signs; IQR = InterQuartile Range; WAD_R =WAD Responders; WAD_NR =WAD Non Responders.
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ANOVA revealed significant differences between the three
groups for elbow extension ROM (F2,100 = 27.72, p < 0.001;
Table 4). Post-hoc tests showed that the WAD_R and
WAD_NR groups demonstrated restricted elbow extension
ROM when compared to healthy controls (p < 0.001).
There were no significant differences between the whiplash
groups (p = 0.87).
Nociceptive flexion reflex
ANOVA revealed significant differences between the
three groups for NFR threshold (F2,116 = 5.52, p < 0.01;
Table 4). Post-hoc tests showed that the whiplash groups
required less current to elicit the reflex than the healthy
control subjects (p < 0.05). There were no significant dif-
ferences between the two whiplash groups (p = 1.00).
Range of motion
MANOVA revealed significant differences between the
three groups in ROM (F8,228 = 22,88, p < 0.001). Post-hoc
tests revealed that the two whiplash groups demon-
strated significant less ROM compared to the healthy
control subjects (F4,114 = 62.29, p < 0.001). There were
no statistically significant differences in ROM in any dir-
ection between the two whiplash groups (F4,114 = 1.09,
p = 0.37; Figure 2).
Cranio-cervical flexion test
MANOVA revealed significant differences between the
three groups for EMG activity of the superficial neck
muscles at all stages of the cranio-cervical flexion test
(CCFT: F10,224 = 3.34, p < 0.001). Post-hoc tests revealed
significant differences between the whiplash and healthy
control groups (F5,112 = 5.98, p < 0.001). No statistically
significant differences existed between the two whiplash
groups (F5,112 = 1.7, p = 0.14; Figure 3).
Psychological measures
The median scores, interquartile ranges and proportion
of participants exceeding threshold scores for GHQ-28,
PCS, and PDS for the three groups are presented in
Table 5.
Both whiplash groups demonstrated significantly higher
GHQ-28 total scores (H = 38.2, 2 d.f., p < 0.001) comparedto healthy controls. There was also a significant greater
proportion of whiplash individuals with generalized psy-
chological distress (GHQ-28 > 23/24, p < 0.001) - 64% of
WAD_R individuals and 66% of WAD_NR individuals
scored above threshold (>23/24), compared to 7% of
controls. There was no significant difference in psy-
chological distress between the two whiplash groups
(LSD = 8.1, p > 0.05).
There was no difference in the proportion of individ-
uals in the two whiplash groups fulfilling the criteria for
PTSD (χ2 = 1.90, 1 d.f., p = 0.168) with 29% of WAD_R
and 44% of WAD_NR group meeting the PDS criteria.
The results also suggest that there is no statistically signifi-
cant difference between the post traumatic stress severity
scores of the two whiplash groups (z = 1.69, p = 0.09).
There was a significantly greater proportion (χ2 =
12.22, 1 d.f., p < 0.001) in the WAD_NR group (50%)
with elevated Pain Catastrophization scores (PCS ≥ 30)
[54], compared to 16% in the WAD_R group. Signifi-
cantly higher PCS scores were also reported by the
WAD_NR individuals (z = 2.7, p = 0.006).
Discussion
Our hypothesis, that individuals with chronic WAD who
did not respond to FB procedures (WAD_NR), would
have greater sensory, sensori-motor and psychological
features than responders (WAD_R) was largely rejected;
with few between group differences demonstrated. How-
ever, the results did reveal that both WAD groups were
different to the healthy controls (HC). Possible reasons
for these findings are discussed.
Our participants with WAD presented similar profiles
to previous studies and support findings that chronic
WAD demonstrates a complex clinical presentation in-
cluding sensory hypersensitivity, sensori-motor dysfunc-
tion and psychological distress [66,67]. Pain and disability
levels were comparable to other patients undergoing MBB
[17,18,22,68]. Some individuals reported an extensive dur-
ation of neck pain, and although the literature indicates
the episodic nature of neck pain over time [69], all individ-
uals reported that their symptoms were attributable
to an original MVC. In concert with other studies, our par-
ticipants reported lower pain thresholds to pressure and
thermal stimuli [70-72] heightened responses bilaterally
Table 4 Median [Interquarterile range] scores and p values for sensory measures














L R L R L R L R
HC (30) 327 [246-410] 363 [302-466] 336 [286-429] 377 [305-518] 531 [471-692] 575 [472-743] 3.5 [0-8.1] 47.5 [45.7-48.8] 47.4 [45.9-48.7] 3 [0-9] 21 [10-38]
WAD_R (58) 171* [141-238] 185* [139-230] 226* [179-284] 249* [186-292] 315* [254-368] 337* [284-424] 19.7‡ [11.3-25.4] 42.7‡ [40.2-47.4] 41.7‡ [39.4-45.6] 30* [18-40] 12‡ [8-18]
WAD_NR (32) 166* [120-229] 149* [110-257] 231* [177-285] 229* [166-288] 322* [252-425] 338* [237-471] 17.4‡ [6.4-26.4] 44.2‡ [40.2-47.0] 42.6‡ [37.9-46.6] 34* [24-44] 12‡ [8-16]
MANOVA p<0.001 p<0.001 p<0.001 Kruskal-Wallis: p<0.001 Kruskall-Wallis: p<0.001 ANOVA: p<0.001 ANOVA: p<0.01
Legend: PPT = Pressure Pain Threshold; kPa = kilopascals; Cx = Cervical; Med =Median Nerve; TibAnt = Tibialis Anterior; CPT = Cold Pain Threshold; HPT = Heat Pain Threshold; BPPT = Brachial Plexus Provocation Test;




















Figure 2 Comparison of cervical ROM between groups.
ROM = Range of Motion; HC = Healthy Controls; WAD_R = WAD
Responders; WAD_NR =WAD Non-Responders; (L) = Left; (R) = Right.
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creased cervical ROM [35,36,75] and impaired control of
cranio-cervical flexion [11,36,76]. Our healthy control
data were likewise similar to that previously reported
[11,77,78]. The psychological profile of our whiplash par-
ticipants is also consistent, with high levels of psychological
distress [15,16], moderate post traumatic stress symptoms
[79] and levels of pain catastrophizing [80] evident.
The presence of sensory hypersensitivity likely reflects
central nervous system hyperexcitability [81,82] indicating
that similar nociceptive processes underlie the conditions
of both groups. Higher levels of pain and disability have
been associated with the presence of these sensory fea-
tures in WAD [8] and 82% of our participants reported
moderate to severe levels of pain related disability. Thus, it
could be expected that sensory hypersensitivity would be a
feature of both groups irrespective of responsiveness to
the joint block techniques. There were also no differences
in measures of motor function between the two whiplashFigure 3 Cranio-cervical flexion test performance across groups.
RMS = Root Mean Square; HC = Healthy Controls; WAD_R =WAD
Responders; WAD_NR =WAD Non-Responders.groups. Loss of neck movement and impaired performance
on the CCFT are also features of other neck pain condi-
tions including non-traumatic idiopathic neck pain and
cervicogenic headache [35,83]. Whilst there may be some
relationship with levels of pain and disability [36], the uni-
form presence of motor dysfunction across neck pain con-
ditions suggest that our findings are not unexpected.
Levels of psychological distress as measured with the
GHQ-28 were no different between our whiplash groups
and are not surprising considering the levels of pain and
disability reported by the participants. Whilst not reach-
ing statistical significance, a greater proportion of non-
responders fulfilled the criteria for a PTSD diagnosis on
the PDS questionnaire (44% of non-responders versus
29% of responders) and reported higher symptom sever-
ity levels. The lack of statistical significance may be a
consequence of the sample size of the study and this fac-
tor requires further investigation, especially given recent
studies that demonstrate a relationship between PTSD,
and pain/disability in WAD [84-86].
There was one notable difference between the two
whiplash groups. Higher levels of pain catastrophization
were demonstrated in the WAD_NR group. Catastrophi-
zation has been associated with enhanced pain reports,
concurrent disability [80,87] and lower pain threshold/
tolerance levels, but is not significantly related to noci-
ceptive flexion reflex (NFR) threshold in healthy and
clinical pain samples [10,88]. Sullivan et al. [31] reported
that higher levels of catastrophization predicted higher
levels of pain following medical procedures, such that
these individuals may actually be less responsive to inva-
sive interventions. It is possible that the higher levels of
catastrophization and tendency towards higher psycho-
logical distress and post traumatic stress symptoms ob-
served in the WAD_NR group may have contributed to
the lack of response to the facet joint injection. The
exact mechanisms responsible for this lack of respon-
siveness require further investigation, but may even in-
clude diminished placebo responses, where individuals
may not ‘believe’ in the blocks or invasive procedures.
Alternately, the higher PCS scores in our non-responder
group may be a consequence of the study methodology.
PCS scores were obtained following diagnostic facet joint
procedures in both whiplash groups. It is possible that a
lack of response may increase levels of catastrophization.
The WAD_NR group reported greater medication in-
take than the responder group and this was the case for
all medication types. Given that pain and disability levels
were no different between the groups, it could suggest
that higher levels of catastrophization may explain the
need for increased medication; or alternately, the lack of
effectiveness of medication in reducing pain and disability
may result in higher levels of catastrophization. There is
some data available to support the initial claim suggesting
Table 5 Median [Interquartile range] scores of each group for psychological measures
Group (n) GHQ-28% ≥23 Score [IQR] PCS % ≥30 Score [IQR] PDS % met criteria probable PTSD Severity score [IQR]
WAD_R (58) 64% 24* [19-32] 16% 15 [7-23] 29% 7 [2-13]
WAD_NR (32) 66% 28* [21-41] 50%* 30‡ [13-39] 44% 12 [5-20]
HC (30) 7% 14 [10-16]
Legend: GHQ = General Health Questionnaire; PCS = Pain Catastrophization Scale; PDS = Post Traumatic Stress Diagnostic Scale; WAD_R =WAD Responders;
WAD_NR =WAD Non Responders; HC = Healthy Controls; *p < 0.001; ‡p < 0.01.
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intake [33]. However, this requires further investigation.
The few differences found between the two groups in
both physical and psychological measures would seem to
indicate that similar processes are contributing to the
clinical presentation, regardless of whether or not facet
joint nociception is involved. It is possible that the
WAD_NR group may have nociception arising from
other structures. Cadaver and biomechanical studies in-
dicate that various cervical spine structures can be po-
tentially injured during whiplash trauma mechanisms
and structures other than the cervical facet joints may
be responsible for ongoing nociception [89-91]. How-
ever, it has also been proposed that factors other than
peripheral nociception, for example physiological stress
responses, can induce hyperalgesic responses and these
may explain the presence of various symptoms in indi-
viduals with chronic WAD [92-94]. Future studies are
currently underway to investigate the attenuation of the
physical and psychological features of chronic WAD fol-
lowing modulation of facet joint nociception, to assist in
understanding this relationship further.
Wasan et al. [27] previously demonstrated that psychi-
atric co-morbidity is associated with reduced pain reduc-
tion following MBB, however they utilized different scales
(Hospital Anxiety and Depression Scale); focussing on
symptoms of anxiety and depression whereas this current
study evaluated psychological distress (GHQ) and post
traumatic stress symptoms (PDS). It may be that affective/
anxiety symptoms have a greater association with response
to MBB. Additionally, symptoms may not be as important
as actual diagnosis in predicting response to MBB. There
was certainly a trend towards an increased proportion of
PTSD diagnoses in the WAD_NR group that may be of
significance in a larger study. Therefore, further in-
vestigation of psychological diagnoses, and the role of pain
catastrophization and posttraumatic stress symptoms
in outcomes following procedural interventions would
be indicated.
Consideration must be given to the diagnostic facet
joint blockade procedures and ‘cut-points’ used in our
study. The use of comparative local anaesthetic blocks
or placebo blocks has been advocated to guard against
false positive responses [57]. In this study, two diagnostic
injection procedures were used, IAB followed by MBB.This combination of diagnostic techniques possesses a
similar construct to comparative MBB’s, with individ-
uals reporting relief of their predominant pain for the
duration of the anaesthetic. Target specificity was ensured
with each procedure by the use of radiographic confirm-
ation of contrast medium (without note of radiate spread)
to ensure needle location [95]. The responder patients in
this study reported a consistent response to both proce-
dures (50% or greater decrease in pain intensity).
Whilst placebo blocks are preferred for ensuring diag-
nostic accuracy in the cervical region [96], this was not
possible at the clinic where our study was conducted.
Therefore, whilst the approach used in our clinic was strin-
gent, we cannot fully exclude a placebo effect in responders
or a nocebo effect in non-responders. A lack of differences
between the whiplash groups may have also resulted from
the criterion standard utilized in our study for determining
‘success’ of the intervention. The clinic used in the study
refers individuals for RFN if they report ‘greater than 50%
relief of pain’ following confirmatory MBB. This cut-off
may not be sufficiently sensitive to detect differences be-
tween the responder and non-responder groups. Eighty
percent pain relief has been suggested for use in research
studies [62], but our study was required to use 50% to ad-
here to the protocol required by the clinic involved. Of
note, previous research has shown no difference in clinical
outcomes following RFN when 50% versus 80% pain relief
from FB was used as the criterion standard [60].
It was also noteworthy that more individuals who
failed to respond to the MBB were lost to follow-up. As
Figure 1 demonstrates, 23/55 (42%) people who did not
respond to IAB were lost to follow-up, compared to only
11/69 (16%) of those who responded. Comparison of
these individuals was not possible and the effects on the
results are not known.
Another possible limitation of this study was that the
measures performed in this study were performed by the
study author, who was aware of the study hypotheses,
however considerable care was made to avoid describing
study aims to the participants during the study (and ex-
pectations of results were unknown given it was a descrip-
tive study); however bias is possible when examiners are
not blinded.
This study was a preliminary cross-sectional study to
investigate any physical or psychological differences in a
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not respond to cervical FB procedures. The design has
limitations, but the results serve to inform future predict-
ive studies. Inclusion of the physical measures (i.e. sensory
and motor measures) in future prospective studies, may
be necessary for profiling patients, but is unlikely to be
predictive of response. Our findings do suggest that a
wider raft of psychological measures be explored, given
some differences in these domains. In addition, the inclu-
sion of measures such as locus of control, coping styles
and expectations, may ultimately assist the clinical selec-
tion of patients for FB procedures.
Conclusion
Individuals with chronic WAD who respond and who do
not respond to facet joint injections display similar com-
plex clinical manifestations involving sensory disturbances,
motor dysfunction and psychological distress. The pres-
ence of high levels of pain catastrophization and post-
traumatic stress symptoms requires further investigation to
determine their roles in non-responsiveness to FB.
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